Join us on 24 and/or 27 January for the 2-day Immunotherapy Hybrid Study Day.
24 January 2025:
27 January 2025:
Health care professionals involved in treating patients on immunotherapy, academics involved in cancer research or anyone with an interest in this field.
This event is supported by the following companies, who have had no input into the agenda, topics or choice of speakers unless where stated.
All tickets (on-site and virtual) include access to the event recordings, resources and presentations for up to 6 months post-event date.
Sign up for the The Cancer Immunotherapy Revolution event on Eventbrite today
| Time | Session |
|---|---|
| 8.30 | Registration |
| 9.00 | Welcome and introductions TBC |
| 9.10 | Basic Tumour Immunology Including Cancer Immunity Cycle Dr Jonathan Lim, Clinical Senior Lecturer and Honorary Consultant Medical Oncologist in AICT, University of Manchester and The Christie NHS Foundation Trust |
| 9.35 | Biomarkers for Immunotherapy Dr Zayd Tippu, Clinical Research Fellow, The Royal Marsden NHS Foundation Trust and The Francis Crick Institute |
| 10.10 | Question and answer session |
10.15 - break
| Time | Session |
|---|---|
| 10.30 | Checkpoint Inhibitors - Rationale For Use Dr Johnathan Worboys, Welcome Trust Research Fellow, University of Manchester |
| 10.55 | Clinical Application of Checkpoint Inhibitors Dr Rebecca Lee, Consultant Medical Oncologist and Honorary Senior Lecturer, The Christie NHS Foundation Trust and University of Manchester |
| 11.30 | Developments and Challenges of Checkpoint Inhibitor Treatments Dr Anna Olsson-Brown, Consultant Medical Oncologist, University Hospitals Sussex NHS Foundation Trust |
12.05 - lunch
| Time | Session |
|---|---|
| 12.40 | Astra Zeneca Sponsored symposium: A Specialist, Pan-Tumour Immunotherapy Service Dr Anna Olsson-Brown, Consultant Medical Oncologist, University Hospitals Sussex NHS Foundation Trust |
| 12.55 | Bispecific Antibodies Dr Ik Shin Chin, Senior Clinical Fellow in ECMT/AICT, The Christie NHS Foundation Trust |
| 13.20 | Cancer Vaccines Dr Aine O’Reilly, Senior Clinical Fellow in ECMT, The Christie NHS Foundation Trust |
| 13.45 | Question and answer session |
13.55 - break
| Time | Session |
|---|---|
| 14.15 | Immune Effector Cell Therapies - TILS, TCR and CAR-T Therapies Dr Andrew Furness, Consultant Medical Oncologist and Lead for Solid Tumour Cell Therapy, The Royal Marsden NHS Foundation Trust |
| 14.50 | Delivering Immune Effector Cells in Practice Jess Longland, Research Nurse Team Leader, ECMT/Cell Therapies, The Christie NHS Foundation Trust |
| 15.15 | Toxicity from Immune Effector Cells In Therapies Professor Fiona Thistlethwaite, Consultant Medical Oncologist in ECMT/AICT and Honorary Professor, The Christie NHS Foundation Trust |
| 15.40 | Summary and close TBC |
17.00 - close
| Time | Session |
|---|---|
| 8.30 | Registration |
| 9.00 | Welcome and introductions Dr Maria Serra, Consultant in Clinical Oncologist, The Christie NHS Foundation Trust |
| 9.05 | Evolution of Immunotherapy And Understanding Roots of Adverse Reactions Prof Paul Lorigan, Consultant In Medical Oncologist, The Christie NHS Foundation Trust |
| 9.30 | Uveitis and Eye Toxicities Mr Eleftherios Agorogiannis, Consultant Ophthalmologist, Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust |
| 9.50 | Discussion |
| 10.00 | Insights to Endocrinology Toxicities Dr Safwaan Adam, Consultant Endocrinologist, The Christie NHS Foundation Trust |
| 10.30 | Discussion |
10.40 - break
| Time | Session |
|---|---|
| 10.55 | Managing Immunotherapy– Induced Colitis Dr Caroline Henson, Consultant Gastroenterologist, Wythenshawe Hospital, Manchester University NHS Foundation Trust |
| 11.25 | Discussion |
| 11.35 | Musculoskeletal Immune related toxicities Dr Sahena Haque, Consultant Rheumatologist, Wythenshawe Hospital, Manchester University NHS Foundation Trust |
| 12.05 | Discussion |
| 12.15 | Immune - Related Cardiovascular Risks Dr Rebecca Dobson, Consultant Cardiologist Liverpool Heart and Chest Hospital, Liverpool, UK |
| 12.45 | Discussion |
12.55 - lunch
| Time | Session |
|---|---|
| 13.40 | Nephrotoxicity Dr James Tollitt, Consultant Nephrologist Salford Royal Hospital, Northern Care Alliance |
| 14.00 | Discussion |
| 14.10 | Neurological Toxicities Dr Ryan Keh, Consultant Neurologist Salford Royal Hospital, Northern Care Alliance |
| 14.40 | Discussion |
| 14.50 | Immune - Related Hepatitis Dr Martin Prince, Consultant Hepatologist, Wythenshawe Hospital, Manchester Royal Infirmary NHS Foundation Trust |
| 15.10 | Discussion |
15.20 - break
| Time | Session |
|---|---|
| 15.35 | Immune-Related Pneumonitis Dr Jonathan Hiu N. Chung, Consultant Respiratory Physician, Wythenshawe Hospital, Manchester University NHS Foundation Trust |
| 16.05 | Discussion |
| 16.15 | Skin Toxicities Dr Elaine Hindle, Consultant Dermatologist Mersey and West Lancashire Teaching Hospitals NHS Trust |
| 16.45 | Discussion |
| 16.55 | Closing remarks |
17.00 - close
If you are interested in sponsorship opportunities, see how you can support the development of cancer education and patient care.
Read Education events sponsorship opportunities Article© 2024 The Christie NHS Foundation Trust
The Christie Charity
